The Evolving Role of Tavlesse® (fostamatinib)
To view the Prescribing Information and Adverse Event Reporting Information, please click the links below:
Tavlesse® (fostamatinib) 100-mg film-coated tablets – click here
Tavlesse® (fostamatinib) 150-mg film-coated tablets – click here
UK-TVLS-2600023 | Date of Preparation: August 2026